Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | PTPRZ1 | P23471 | 4/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.41 |
| ▸ | ABAT | P80404 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24512641 | 0.89 | PTPRZ1 (0.46) | ALDH1A1KDM4ETDP1PTPRZ1PTPN1 | |
| SCHEMBL6685855 | 0.80 | PTPRZ1 (0.77) | ALDH1A1KDM4ETDP1PTPRZ1PTPN1 | |
| SCHEMBL5057067 | 0.77 | ALDH1A1 (0.58) | ALDH1A1KDM4ECYP2A6HSD17B10ALDH5A1 | |
| SCHEMBL695549 | 0.77 | ALDH1A1 (0.52) | ALDH1A1KDM4ETDP1PTPRZ1PTPN1 | |
| SCHEMBL5399931 | 0.77 | ALDH1A1 (0.52) | ALDH1A1KDM4ETDP1PTPRZ1PTPN1 | |
| SCHEMBL694683 | 0.77 | ALDH1A1 (0.52) | ALDH1A1KDM4ETDP1PTPRZ1PTPN1 | |
| SCHEMBL7810144 | 0.77 | ALDH1A1 (0.42) | ALDH1A1KDM4ETDP1PTPRZ1PTPN1 | |
| SCHEMBL7810141 | 0.77 | ALDH1A1 (0.42) | ALDH1A1KDM4ETDP1PTPRZ1PTPN1 | |
| SCHEMBL30540204 | 0.75 | ALDH1A1 (0.44) | ALDH1A1KDM4ETDP1PTPRZ1PTPN1 | |
| SCHEMBL9110887 | 0.75 | KIF11 (0.51) | ALDH1A1KDM4ETDP1PTPRZ1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118546103-A | 4-Formamide oxazole compound and preparation method and application thereof | 上海大学 | 2024-08-27 | — | — | CN | claimed |
| CN-104093709-B | It is used as the imidazole derivative of aldosterone synthase inhibitors | 霍夫曼-拉罗奇有限公司 | 2017-09-22 | — | — | CN | claimed |
| CN-104093709-A | Imidazolylketone derivatives as aldosterone synthase inhibitors | HOFFMANN LA ROCHE | 2014-10-08 | — | — | CN | claimed |
| US-12568969-B2 | Pyridine compounds for controlling invertebrate pests | FMC CORPORATION (US) | 2026-03-10 | — | — | US | disclosed |
| US-20250223301-A1 | KINASE INHIBITORS, PREPARATION METHODS AND USES THEREOF | InventisBio Co., Ltd. (CN) | 2025-07-10 | — | — | US | disclosed |
| EP-4499640-A1 | KINASE INHIBITORS, PREPARATION METHODS AND USES THEREOF | InventisBio Co., Ltd. (CN) | 2025-02-05 | — | — | EP | disclosed |
| WO-2024212742-A1 | GLP-1R AGONIST, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海研健新药研发有限公司 | 2024-10-17 | — | — | WO | disclosed |
| WO-2024141128-A4 | STING INHIBITOR PRODRUG AND MEDICAL USE THEREOF | 中国药科大学 | 2024-09-19 | — | — | WO | disclosed |
| CN-118546103-A | 4-Formamide oxazole compound and preparation method and application thereof | 上海大学 | 2024-08-27 | — | — | CN | disclosed |
| WO-2024141128-A2 | STING INHIBITOR PRODRUG AND MEDICAL USE THEREOF | 中国药科大学 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024125629-A1 | UREIC COMPOUND AND PHARMACEUTICAL USE THEREOF AS STING INHIBITOR | 中国药科大学 | 2024-06-20 | — | — | WO | disclosed |
| EP-0294229-B1 | NOVEL HETEROCYCLIC PESTICIDAL COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-12-02 | — | — | EP | disclosed |
| CN-1030236-A | NOVEL HETEROCYCLIC PESTICIDAL COMPOUNDS | WELLCOME FOUND (GB) | 1989-01-11 | — | — | CN | disclosed |
| EP-0294229-A2 | Novel heterocyclic pesticidal compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1988-12-07 | — | — | EP | disclosed |
| US-4588844-A | Process for preparing aromatic aldehydes | BAYER AKTIENGESELLSCHAFT (DE) | 1986-05-13 | — | — | US | disclosed |
| US-4384114-A | Styryl substituted Γ-lactone derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 1983-05-17 | — | — | US | disclosed |
| EP-0019713-B1 | PROCESS FOR THE PREPARATION OF STYRYL-CYCLOPROPANE CARBOXYLATES, INTERMEDIATES THEREFOR AND THEIR PRODUCTION | BAYER AG (DE) | 1983-02-16 | — | — | EP | disclosed |
| US-4327025-A | Preparation of styryl-cyclopropane-carboxylic acid esters and intermediate therefor | BAYER AKTIENGESELLSCHAFT (DE) | 1982-04-27 | — | — | US | disclosed |
| EP-0019713-A1 | Process for the preparation of styryl-cyclopropane carboxylates, intermediates therefor and their production | BAYER AG (DE) | 1980-12-10 | — | — | EP | disclosed |
| US-4104379-A | DOPAMINERGIC ACTIVITY | SMITHKLINE CORPORATION (US) | 1978-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250223301-A1 | KINASE INHIBITORS, PREPARATION METHODS AND USES THEREOF | MAP3K19, MAP3K1, MAP3K20 | ALDH1A1 4498/4885KDM4E 1816/4885TDP1 1159/4885 |
| US-12568969-B2 | Pyridine compounds for controlling invertebrate pests | COX6C, CCR1, CBR3 | ALDH1A1 1464/4885KDM4E 1584/4885TDP1 2671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.